Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynamin 1 pseudogene 31 (DNM1P31; also known as DNM1DN4-2) is a predicted pseudogene in the human genome, related to the protein-coding gene DNM1 (Dynamin 1). DNM1P31 is not expressed as a functional protein and does not participate in biological processes such as signal transduction, endocytosis, or vesicle trafficking. Its presence is a result of evolutionary duplication events[2]. The functional gene DNM1 encodes a GTPase involved in membrane fission events and is relevant to neurological diseases and some cancer types[1][3][5], but DNM1P31 itself has no direct biological or pharmacological role. Summary of issues: - DNM1P31 is a pseudogene: It does not produce a functional protein and is not a therapeutic target[2]. - Not classified as a molecular target: It lacks drug, biomarker, and safety data. - Confusion risk: Scientific literature and drug development focus on *dynamin 1* (DNM1), not DNM1P31. For drug discovery or therapeutic targeting, you should refer to the canonical protein-coding gene **Dynamin 1** (*DNM1*), not **Dynamin 1 pseudogene 31** (*DNM1P31*)[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynamin 1 pseudogene 31 (DNM1P31).